Last reviewed · How we verify

NCT06173583

ARISCAT and LAS VEGUS Risk Scores for Predicting Postoperative Pulmonary Complications After Cardiac Surgery

Completed Last updated 14 February 2024
What this trial tests

trial testing Detection/screening in Pulmonary Complication in 181 participants. Completed in 31 January 2021.

Timeline
14 February 2020
Primary endpoint
31 January 2021
31 January 2021

Quick facts

Lead sponsorAga Khan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment181
Start date14 February 2020
Primary completion31 January 2021
Estimated completion31 January 2021
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Aga Khan University

Who can join

Adults 18 to 65, any sex, with Pulmonary Complication or Postoperative Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to compare the, ARISCAT and LAS VEGUS scales, for predicting postoperative pulmonary complications in patients undergoing cardiac surgery. The study aims to compare the diagnostic accuracies of the two risk prediction scores in predicting postoperative pulmonary complications.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. ARISCAT and LAS VEGAS risk scores for predicting postoperative pulmonary complications after cardiac surgery: a cohort study.
    Siddiqui KM, Farooqui MH, Yousuf MS, Ali MA. · · 2024 · PMID 38989237 · DOI 10.1097/ms9.0000000000002191

Verify or expand the search:

Other recruiting trials for Pulmonary Complication

Currently open trials in the same condition.

Other Aga Khan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06173583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing